Ayala Pharmaceuticals Company
Ayala Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops targeted cancer therapies for people with genetically defined cancers. The company manufactures gamma secretase inhibitors as targeted treatments for cancers harboring specific notch alterations. The company was founded in 2017 and is based in Rehovot, Israel.
Founded Date:
2017
Headquarters:
Rehovot, Israel
Technology:
Biotechnology, Pharmaceutical
Employee Number:
10-50
Industry:
Personalized Medicine
Number Of Exists:
N/A
Funding Status:
Early Stage Venture
Investor Type:
N/A
Investment Stage:
N/A